Beijing Sunho Pharmaceutical Co (BJSE:920017) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920017 Beijing Sunho Pharmaceutical Co Ltd BJSE:920017
80 GF Score
Price ¥15.67
GF Value ¥15.19
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Beijing Sunho Pharmaceutical Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Beijing Sunho Pharmaceutical Co Valuation Rank Related Terms

BJSE:920017
80GF Score
Beijing Sunho Pharmaceutical Co Ltd BJSE:920017
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Beijing Sunho Pharmaceutical Co (BJSE:920017) Overvalued in 2026?

Based on GuruFocus' analysis, Beijing Sunho Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥15.67 is trading 3.2% above its estimated GF Value™ of ¥15.19. GuruFocus considers Beijing Sunho Pharmaceutical Co to be Fairly Valued.

Key valuation signals for BJSE:920017:

  • Valuation Rank:
  • GF Value™: ¥15.19 vs. price of ¥15.67 (3.2% above fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the BJSE:920017 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Beijing Sunho Pharmaceutical Co Business Description

Address No. 18, Zhonghe Street, Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Beijing Sunho Pharmaceutical Co Ltd engages in the research and development, production, and sales of pharmaceutical preparations while providing CMC/CMO integrated services for pharmaceutical preparation manufacturers and drug R&D enterprises. The company produces small-volume injections, freeze-dried powder injections, hard capsules, tablets, and other products. The company's main products included: compound digestive enzyme capsules, piracetam (small injection and powder injection), and oxalic acid acetate.
80GF Score

Get the complete analysis for BJSE:920017

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.67
Price
¥15.19
GF Value